59 related articles for article (PubMed ID: 32069895)
1. SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair.
El Bezawy R; Tripari M; Percio S; Cicchetti A; Tortoreto M; Stucchi C; Tinelli S; Zuco V; Doldi V; Gandellini P; Valdagni R; Zaffaroni N
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32512734
[TBL] [Abstract][Full Text] [Related]
2. Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease.
Zhou Y; Liu Z; Lynch EC; He L; Cheng H; Liu L; Li Z; Li J; Lawless L; Zhang KK; Xie L
Lab Invest; 2021 Apr; 101(4):477-489. PubMed ID: 33005011
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced Circular RNA hsa_circ_0006508 Promotes the Warburg Effect in Colorectal Cancer Cells.
Xu Y; Zhang Y; Hao W; Zhao W; Yang G; Jing C
Balkan Med J; 2023 Jan; 40(1):21-27. PubMed ID: 36397308
[TBL] [Abstract][Full Text] [Related]
4. Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.
Huseinovic A; Jaspers A; van Splunter AP; Sørgård H; Wilting SM; Swarts DRA; van der Meulen IH; van Beusechem VW; de Menezes RX; Steenbergen RDM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563182
[TBL] [Abstract][Full Text] [Related]
5. The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer - A Systematic Review.
Soares S; Guerreiro SG; Cruz-Martins N; Faria I; Baylina P; Sales MG; Correa-Duarte MA; Fernandes R
Front Oncol; 2021; 11():704664. PubMed ID: 34414113
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer.
Doldi V; El Bezawy R; Zaffaroni N
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069147
[TBL] [Abstract][Full Text] [Related]
7. miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.
Arrighetti N; Beretta GL
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33805590
[TBL] [Abstract][Full Text] [Related]
8.
Rotundo F; Cominetti D; El Bezawy R; Percio S; Doldi V; Tortoreto M; Zuco V; Valdagni R; Zaffaroni N; Gandellini P
Cells; 2020 Feb; 9(2):. PubMed ID: 32069895
[TBL] [Abstract][Full Text] [Related]
9. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
[TBL] [Abstract][Full Text] [Related]
10. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
12. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
